Scaling beta-lactam antimicrobial pharmacokinetics from early life to old age.

Critical illness is associated with greater PK variability than in healthy volunteers. The maturation models presented will be useful for optimizing beta-lactam dosing, although a prospective, age-inclusive study is warranted for external validation.